Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$660M |
| 2 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$173M |
| 3 |
Altria Group
MO
|
+$145M |
| 4 |
Verizon
VZ
|
+$134M |
| 5 |
United Parcel Service
UPS
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
+$181M |
| 2 |
iShares MSCI Germany ETF
EWG
|
+$148M |
| 3 |
Apple
AAPL
|
+$127M |
| 4 |
abrdn Physical Gold Shares ETF
SGOL
|
+$106M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.3% |
| 2 | Financials | 12.48% |
| 3 | Healthcare | 11.72% |
| 4 | Consumer Discretionary | 11.3% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCRR
2226
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $4.94M | ﹤0.01% |
159,587
+779
| +0.5% | +$19.7K |
|
|
XENT
2227
DELISTED
Intersect ENT, Inc
XENT
| $4.93M | ﹤0.01% |
215,407
+2,875
| +1% | +$54.7K |
|
|
CCF
2228
DELISTED
Chase Corporation
CCF
| $4.91M | ﹤0.01% |
48,615
+203
| +0.4% | +$21.3K |
|
2229
American Public Education
APEI
$980M
| $4.91M | ﹤0.01% |
161,067
-4,950
| -3% | -$152K |
|
2230
Prelude Therapeutics
PRLD
$360M
| $4.91M | ﹤0.01% |
+68,568
| New | +$3.41M |
|
2231
Pulmonx
LUNG
$87M
| $4.9M | ﹤0.01% |
+71,041
| New | +$3.48M |
|
|
MCHB
2232
Mechanics Bancorp
MCHB
$3.7B
| $4.9M | ﹤0.01% |
145,134
-4,477
| -3% | -$144K |
|
2233
International Seaways
INSW
$4.58B
| $4.89M | ﹤0.01% |
299,726
+17,130
| +6% | +$275K |
|
2234
DXP Enterprises
DXPE
$2.65B
| $4.89M | ﹤0.01% |
219,943
+12,762
| +6% | +$258K |
|
2235
Amphastar Pharmaceuticals
AMPH
$877M
| $4.87M | ﹤0.01% |
242,148
+5,016
| +2% | +$97.6K |
|
2236
Teva Pharmaceuticals
TEVA
$40.1B
| $4.86M | ﹤0.01% |
503,414
+13,232
| +3% | +$127K |
|
2237
iQIYI
IQ
$1.28B
| $4.86M | ﹤0.01% |
277,708
+1,754
| +0.6% | +$39.6K |
|
2238
Johnson Outdoors
JOUT
$506M
| $4.85M | ﹤0.01% |
43,039
+197
| +0.5% | +$17.9K |
|
|
PTVE
2239
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $4.82M | ﹤0.01% |
+265,719
| New | +$4.1M |
|
2240
NovaGold Resources
NG
$2.78B
| $4.79M | ﹤0.01% |
495,301
+2,969
| +0.6% | +$31.4K |
|
2241
Brookfield Infrastructure
BIPC
$4.97B
| $4.78M | ﹤0.01% |
99,191
-1,732
| -2% | -$73.4K |
|
2242
Harmonic Inc
HLIT
$1.34B
| $4.77M | ﹤0.01% |
645,165
+6,085
| +1% | +$40K |
|
2243
Precigen
PGEN
$2.33B
| $4.77M | ﹤0.01% |
467,411
+14,537
| +3% | +$94.2K |
|
2244
Liberty Media Series A
FWONA
$22.2B
| $4.75M | ﹤0.01% |
130,565
+2,442
| +2% | +$85.4K |
|
2245
QCR Holdings
QCRH
$1.72B
| $4.73M | ﹤0.01% |
119,480
+11,500
| +11% | +$401K |
|
|
ESPR
2246
DELISTED
Esperion Therapeutics
ESPR
| $4.71M | ﹤0.01% |
181,288
+3,263
| +2% | +$97.7K |
|
2247
Purple Innovation
PRPL
$42.4M
| $4.71M | ﹤0.01% |
5,724
-241
| -4% | -$176K |
|
2248
Outset Medical
OM
$96.8M
| $4.7M | ﹤0.01% |
+5,510
| New | +$4.25M |
|
2249
MannKind Corp
MNKD
$1.22B
| $4.69M | ﹤0.01% |
1,498,731
+29,650
| +2% | +$77.7K |
|
2250
Vanda Pharmaceuticals
VNDA
$321M
| $4.68M | ﹤0.01% |
356,282
+1,731
| +0.5% | +$20.8K |
|
Similar funds
Charles Schwab's Q4 2020 Portfolio in Review
As of Q4 2020, Charles Schwab held 3,457 positions worth $252B, up 16% from $217B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q4 2020 filing shows 113 new, 2,243 increased, 711 reduced and 62 closed positions. Its largest new stake was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M. The largest sale was VanEck JP Morgan EM Local Currency Bond ETF, an estimated $181M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2020 buy was Vanguard FTSE Pacific ETF: 993,047 shares worth $79M.
- Charles Schwab added most to Tesla in Q4 2020, an estimated $660M increase.
- Charles Schwab's biggest Q4 2020 reduction was VanEck JP Morgan EM Local Currency Bond ETF, cutting an estimated $181M.
- Charles Schwab fully exited iShares MSCI Germany ETF in Q4 2020, selling an estimated $148M.
- Charles Schwab's ten largest holdings make up 17% of its $252B portfolio in Q4 2020.
- Charles Schwab opened 113 new positions and closed 62 in Q4 2020.
- Charles Schwab's portfolio value rose 16% quarter-over-quarter to $252B.
Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.